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Background: Concerns about unsustainable costs in the US Medicare program loom as the number of retirees
increase and experiences serious and costly illnesses like cancer. Engagement of stakeholders, particularly cancer
patients and their families, in prioritizing insured services offers a valuable strategy for informing Medicare coverage
policy. We designed and evaluated a decision exercise that allowed cancer patients and family members to choose
Medicare benefits for advanced cancer patients.
Methods: The decision tool, Choosing Health plans All Together (CHAT) was modified to select services for
advanced cancer patients. Patients with a cancer history (N = 246) and their family members (N = 194) from North
Carolina participated in 70 CHAT sessions. Variables including participants’ socio-demographic characteristics, health
status, assessments of the exercise and results of group benefit selections were collected. Routine descriptive
statistics summarized participant characteristics and Fisher’s exact test compared group differences. Qualitative
analysis of group discussions were used to ascertain reasons for or against selecting benefits.
Results: Patients and family members (N = 440) participated in 70 CHAT exercises. Many groups opted for such
services as palliative care, nursing facilities, and services not currently covered by the Medicare program. In
choosing among four levels of cancer treatment coverage, no groups chose basic coverage, 27 groups (39%)
selected intermediate coverage, 39 groups (56%) selected high coverage, and 4 groups (6%) chose the most
comprehensive cancer coverage. Reasons for or against benefit selection included fairness, necessity, need for
prioritizing, personal experience, attention to family needs, holistic health outlook, preference for comfort, freedom
of choice, and beliefs about the proper role of government. Participants found the exercise very easy (59%) or fairly
easy (39%) to understand and very informative (66%) or fairly informative (31%). The majority agreed that the CHAT
exercise led to fair decisions about priorities for coverage by which they could abide.
Conclusions: It is possible to involve cancer patients and families in explicit discussions of their priorities for
affordable advanced cancer care through the use of decision tools designed for this purpose. A key question is
whether such a conversation is possible on a broader, national level.
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Design of health care benefit programs, especially na-
tional coverage schemes such as the United State’s Medi-
care program or the United Kingdom’s National Health
Service, must account for competing pressures and in-
terests, and high profile reform discussions in both na-
tions are ongoing [1-4]. Optimal health is an obvious
goal, but the design of benefit programs must be bal-
anced by the cost of care. Other important consider-
ations include the need for benefit packages of public
programs to accommodate both the needs and prefer-
ences of large and diverse groups of patients and their
family members, and to allow health care providers to
treat their patients as they see fit within the professional
norms of a given nation. As populations age and health
care costs increase, a key question for western democra-
cies is what health care benefit options should be pro-
vided as an entitlement in public programs?
Finding the proper balance between access to an ex-
pansive and flexible benefit package and the affordability
of providing such a package is not a theoretical exercise,
but a practical problem that is ideally addressed by
obtaining the insight of a variety of perspectives, includ-
ing those of patients and family members. But how and
why is it important?
Administered by the U.S. federal government since
1966, Medicare is the national social insurance pro-
gram that guarantees access to health insurance for
Americans aged 65 and older who have worked and
paid into the system (or who are married to someone
who has), and younger people with disabilities. The
benefit coverage decisions of Medicare have come to
define not only those services to which the elderly are
eligible to receive, but have evolved to practically define the
standard of what care is “reasonable and necessary”
throughout the entire health care system. Any change in
what Medicare covers will influence the entire health care
system [5,6]. People with cancer, and especially those with
metastatic disease, have complex health care needs often
requiring progressively more expensive cancer treatments
(with unclear benefits and vague stopping points) superim-
posed on accelerating disease and treatment-related symp-
tom burden as well as other needs requiring palliative
intervention. From an insurance design standpoint, sorting
out what could be provided and what is optimal to be of-
fered is likely to be more difficult for cancer than for other
diseases, in part because of the rapid increase in treatments
without clear information about when they are warranted
[7]. Finally, it is much simpler to state that there is a long
run financing gap between expected expenditures and tax
flows under current policy than it is to devise a different
policy. For such a politically difficult task, the views of
those most directly involved (e.g., those with cancer and
family members) are needed to increase the chance ofbringing about any consequential change in this area. In
order to best devise policy, better information about the
priorities of patients and family members dealing with
cancer can be elicited using participatory decision tool
processes.
The most compelling American approach to measure
public preferences has been the Choosing Health plans
All Together (CHAT) exercise, which has been used
with over 4,000 lay participants in nine US states over a
decade, to elicit public input in health insurance benefit
design [8]. However, CHAT has only been used with
members of the public without regard to whether they
have a particular diagnosis. To date, it has not been used
to ascertain the priorities of patients and families who
have experienced or are in the midst of experiencing an
illness.
This paper explores whether the CHAT exercise can
successfully be used with cancer patients and families to
reveal their perspectives in a way that can inform policy
questions about what health care benefit options Medi-
care beneficiaries and their family members would prefer
when faced with a resource constraint. If use of the
CHAT exercise is of value to this patient population and
the Medicare program regarding alignment of priorities,
it may prove to be similarly useful with other patient
populations in the United States or other nations inter-
ested in undertaking patient-centered health plan design,
which is intended to maximize value for individuals and
families so that they receive more benefit and better re-
sults for their health care dollars.
Methods
Participants
Study participants were cancer patients and family mem-
bers of cancer patients recruited from the Duke Com-
prehensive Cancer Center, cancer clinics at Duke
Raleigh Hospital, a variety of health care facilities, and
organizations that serve a large number of senior citi-
zens in the Raleigh-Durham, North Carolina area. This
included continuing care retirement communities, orga-
nizations that provide support to cancer survivors, and
non-profit organizations that aid families who are receiv-
ing health care from Duke University Medical Center.
Two participants were excluded because of insufficient
attendance at a CHAT session. One individual enrolled
but chose not to complete participation.
Use and modification of the CHAT exercise
We used the Choosing Health plans All Together
(CHAT) exercise to create a version for cancer patients
and their families. CHAT is an interactive decision tool
designed to facilitate deliberation by groups comprised
of members of the public in order to select health plan
benefits.
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health plan benefits are represented as pie-shaped cove-
rage options for selection by participants; the circular
presentation avoids a more hierarchical presentation that
might influence selection of options. Participants can
choose benefits at as many as four levels of care and re-
lated expense depicted in concentric rings around the
board (Figure 1). These levels generally offer increasing
degrees of choice, convenience, and expanded services,
and diminishing degrees of out-of-pocket costs.
Participants were each given 50 markers with which to
select health plan benefits. These markers represented
an amount of money comparable to the average annual
expenditure by Medicare enrollees in 2007 as identified
in Medicare claims files. The dollar value was inflated to
2010 dollars, the initial year of CHAT data collection.
Each benefit category could be selected at any level by
placing the specified number of markers on the board;
the number of markers proportionally reflected the ben-
efit’s actuarial cost. It would take 87 markers to choose
the highest level of benefit coverage for all options, so
participants faced a severe resource constraint in making
their selections. Participants were not told the CHAT
game was based on money, but were simply told they
could not choose everything.
CHAT session participants sat at a table and used lam-
inated paper exercise boards with stickers that allowed
them to specify their insurance benefit choices. A
trained facilitator guided participants through the exer-
cise, answered questions, and therefore ensured partici-
pants had credible information about the choices before
they stated their preferences.Figure 1 Advanced cancer CHAT board.Participants made choices about their benefit prefer-
ences in four rounds. During round 1, participants made
benefit selections individually. In Round 2 they worked in
small groups to select benefits by consensus. In Round 3,
all participants decided upon a group benefit package.
Finally, in round 4 they again made benefit selections
individually.
At the outset of the exercise, the facilitator’s script ex-
plained to study participants that the purpose of the
CHAT exercise was to help design a better Medicare
health plan and to help people make informed health
plan choices with a combination of affordable benefits
that are compatible with the needs of patients with
advanced cancer. The facilitator explained the need to
prioritize health plan coverage options in the face of
limited resources and advised participants to refer to
the printed booklet of insurance benefit options (see
Additional file 1 for booklet content). Unlike the usual
CHAT exercise, participants were not instructed to
make benefit packages for themselves but rather for
advanced cancer patients in general. This instruction
was specifically chosen because the study team knew
neither the stage of participant’s cancer nor what these
patients had been told about their disease by their on-
cologists, and were instructed to avoid pressuring par-
ticipants to discuss their personal experiences of living
with cancer with strangers in the group.
After Rounds 1 and 2, the facilitator answered ques-
tions and provided some examples of health events
depicting experiences of advanced cancer patients to
provide needed context for these discussions, and to fa-
cilitate informed and prudent choices. At the beginning
of Round 3, the facilitator gave the following instructions
about the deliberative process:
Now, just as the game says, we’ll “Choose a Health
plan All Together” as one big group. To do this, we’ll
use this Big Game Board (Point to Board at the front
of the room).
You will each take a turn saying what you
recommend and negotiate to get a group decision.
First we’ll ask a player to recommend a category for
basic coverage. If no one objects to what is suggested,
I’ll place red stickers on the Big Exercise Board. If you
don’t agree, let me know and we will discuss that
category. After we’ve considered all categories for the
Basic level of coverage, we can go back and look at
Intermediate and High levels of coverage in the
categories that are important to us. When we get to
the last five stickers or so, the decision may get
tougher. We’ll try to reach agreement. If there are
services you want to give up to pick some other
service that is fine.
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structions about how to take into account supplemental
insurance coverage or their personal incomes. Rather we
were interested in how they might spontaneously take
these factors into account. We now mention this is the
Methods section.
The original CHAT exercise was additionally modified
as follows.
Selection of benefit options
Since the aim of the exercise was to prioritize Medicare
benefits that would offer affordability and address the
goals of care for advanced cancer patients, a range of
options were chosen that were compatible with the full
dimension of services from which advanced cancer pa-
tients might possibly benefit. The major benefit categor-
ies (as shown in the online additional material) include
domains that range from cancer treatments with man-
agement of treatment complications, to preservation of
function, psychosocial support, logistical support, and fi-
nancial support. The benefit categories offered as choices
to participants were selected based upon published data
about the health care needs of people with advanced
life-limiting illness [9,10]. In addition, some of the bene-
fits choices are not currently covered by Medicare: un-
restricted cash that may not typically be viewed as a
benefit in such a health care program, concurrent pallia-
tive care where expansive palliative services could be
accessed without un-electing curative treatments as
now required in the current Medicare hospice benefit,
and in-home custodial long term care services to ad-
dress disability.
Estimation of actuarial cost of benefit options
Actuarial costs of the benefit options were estimated
using the cost of Medicare financed care in the last six
months of life for a claims-based cancer death cohort of
Medicare decedents age 65 and older (5% claims sample,
2007), using the amount paid by Medicare. We identified
decedents who had at least one hospitalization in their
last six months of life with a primary cancer diagnosis
(signified by one ICD-9-CM code in the following
ranges: 140.xx-165.xx, 170.xx, 171.xx, 172.xx, 174.xx,
175.xx, 176.xx, 179.xx-195.xx, 200.xx-208.xx, 236.6×).
Detailed lists of typical drugs were developed for com-
mon types of cancer, and overall costs divided to represent
basic, medium, high, and advanced benefit levels based
upon average costs of care from Medicare claims. Prices
used to finalize cost estimates of the different benefit levels
came from Medicare reimbursement rates, from the lit-
erature, and from local market data for items such as
family members paid time. We compared the Medicare
reimbursement rates to the charges of Duke University
Medical Center for other insurers for comparison purposesto ensure that they were generally aligned. Our cost esti-
mates needed to be general because they were used to de-
velop a CHAT tool for a Medicare sample facing diverse
types of cancer. The goal was to provide a realistic cost vs.
benefit tradeoff for patients and family members.
For those options that we included but do not exist in
the current Medicare benefits, (discretionary cash, con-
current palliative care and expanded LTC), we used in-
ternal Duke University cost estimates as well as local
market estimates to estimate the relative “cost” of these
benefits.
Choosing the maximum level of all benefit categories
would require 87 stickers with an estimated cost of
$60,900; participants only had 50 stickers with which to
choose. While the benefit options were broadly based
on Medicare and other costs, monetary value of benefit
options in the exercise was not explicitly communicated
to CHAT recipients. Participants were simply told they
only had 50 stickers and could not choose everything.
Testing of the exercise
To determine participant assessment of the cancer CHAT
exercise, we used a post exercise questionnaire (four-point
Likert scales) that queried if participants thought the exer-
cise was enjoyable, understandable, easy, and informative.
Participants were also asked about their level of agreement
with a number of attitudinal statements. Discussions dur-
ing Round 3, in which full groups deliberated about and
chose a benefit package, were audiotaped and transcribed
for a subset of 20% the CHAT groups to ascertain the
quality of deliberative process among this unique group of
cancer patients and family members.
Human subjects protection
The Duke University Health System Institutional Review
Board (IRB) approved the study. The Office of Human
Subjects Protection at the Clinical Center of the Na-
tional Institutes of Health exempted the study from IRB
review. Participants gave informed consent and, at the
conclusion of the exercise, were given a check for $75 as
compensation for their participation.
Data analysis
Choices of categories and tiers and responses to pre-
and post-surveys were summarized using descriptive sta-
tistics. Fisher’s exact test was used to test for significant
differences between patient and family member demo-
graphics and choices that were collected during pre-
CHAT surveys, while information on participant views
of the experience were collected during post-CHAT sur-
veys. Transcriptions were reviewed to ascertain the rea-
sons that participants gave for their benefit selections
and verbatim quotes illustrating keys themes were se-
lected for inclusion in the online additional material.
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Participant characteristics
A total of 440 participants (246 patients and 194 family
members) participated in 70 CHAT sessions. Target group
size for CHAT sessions was 8-10 participants, but smaller
groups were also held (smallest CHAT n = 3). Cancer pa-
tients were an average of 73 years of age, 49% were female,
and 26% were African-American. Approximately half of
participating patients had completed college (46%), 36%
had annual household incomes under $40,000, and 50.4%
had spent $2,000 or more out of pocket on medical care
in the prior year. Patients had a wide range of cancer
types. Family members were an average of 64 years of
age. They were predominantly spouses (51%), but they
also included adult children (19%), siblings (4%), and
other adults (20%). There was a statistically significant dif-
ference between patients and family members for age,
gender, marital status, educational attainment, health sta-
tus and out-of-pocket expenses (Table 1).CHAT groups’ coverage priorities
Over 60% of the CHAT groups chose coverage for can-
cer treatment at the two intermediate levels among the
four levels that were offered. Many groups chose to in-
clude all other benefits that are not covered by the
Medicare program including emotional support for pa-
tients and family members (53%), cash assistance (46%),
advice (29%), house calls by physicians (27%), and home
improvements (70%) (Table 2).Qualitative analysis of group deliberations
The reasons that study participants gave to justify their
benefit selections included arguments for the following:
fairness, necessity, need for prioritizing, personal ex-
perience, attention to family needs, holistic health out-
look, preference for comfort, freedom of choice, and
beliefs about the proper role of government. A summary
table showing verbatim quotes in support of or against
each benefit option and which type of argument was
used is shown in Additional file 2.
Because, there is such controversy regarding the ex-
treme cost of some cancer medications, we reviewed those
comments in which participants mentioned their reason-
ing regarding selection of the level of cancer treatment
they endorsed. There was not substantial disagreement re-
garding selection of the level of cancer treatment and thus
few statements justifying the levels selected; only 3 of 14
analyzed group deliberations involved comments about
the level of cancer care selected (Additional file 3).
In contrast, study participants did engage in discussing
the financial ramifications of their benefit choices in gen-
eral. In seven of the 14 analyzed sessions, participants
made explicit statements regarding financial ramificationsof benefit selections (range in the number of comments
per session was 0-22 per session, see Additional file 4).
Because study participants were asked to consider what
they thought advanced cancer patients’ coverage ought to
be rather than to consider what coverage they would wish
to have themselves, we examined how participants’ own
experience contributed to their reasoning they gave during
the deliberative process. Among the recorded sessions, 6
or 14 sessions included at least one comment explicitly
referring to personal experience as a justification for the
benefit selection that the participant was recommending.
Sessions varied widely in the extent of such comments
(ranging from 0 to 25 comments, see Additional file 5).
Attitudes of study participants regarding the exercise
Reactions of patients and families regarding the exercise
were similar and are therefore reported together (Table 3).
Participants found the exercise very enjoyable (73%) or
fairly enjoyable (23%); 2% found the exercise very unen-
joyable. Participants found the exercise very easy to
understand (59%) or fairly easy to understand (39%),
and none found it very hard to understand. They also
found the exercise very informative (66%) or fairly in-
formative (31%; Table 3).
The majority of participants agreed with statements
indicating that the CHAT exercise led to fair decisions
about priorities for coverage, took individual points of
views into account, involved open and honest discussion,
involved realistic choices, and led to group decisions by
which they could abide (Table 3). They also agreed that
asking cancer patients and their families about what
kind of Medicare benefits they recommended was a
good idea. There was distribution across the full range
of opinions, however, and small but vocal minorities of
patients can receive outsized attention. For example,
even though nearly 8 in 10 respondents answered 1
(strongly disagree) or 2 (disagree) to the question “When
I think about CHAT I feel angry” 6.6% strong agree with
this statement. In discussions of health care policy
changes such as the recent health reform discussion in
the U.S., vocal minorities receive a great deal of atten-
tion making any consequential change difficult. One key
question that is telling in this regard is the distribution
of responses to the question “I would be willing to abide
by the group’s choice of Medicare coverage” which only
had around one-third of participants saying strongly
agree, and a similar proportion providing the answer of
3-right in the middle.
The consensus benefit choices made at round 3 (Table 4)
show what options rose to the top when a benefit con-
straint was imposed. Several choices are worth noting. First,
only 4 groups (of 70) choose the maximum level of cancer
treatments even though Medicare commonly finances such
a level of “do everything” care if patients so desire. On the
Table 1 Socio-demographic characteristics and health status of patients (N = 246) and family members (N = 194)
Characteristics Patient (N = 246) Caregiver (N = 194) Combined (N = 440)
Mean age ± SDb 73 ± 7.1 64 ± 10.7 69 ± 10.0
Genderb
Female 120 (48.8) 138 (71.5) 258 (58.8)
Male 126 (51.2%) 55 (28.4%) 181 (41.1%)
Not Answered 0 (0.0%) 1 (0.5%) 1 (0.2%)
Race
Native American 6 (2.5) 2 (1.0) 8 (1.8)
African American 64 (26.3) 67 (34.9) 131 (30.1)
Caucasian 169 (69.5) 120 (62.5) 289 (66.4)
Other 4 (1.6) 3 (1.6) 7 (1.6)
Not Answered 3 (1.2%) 2 (1.0%) 5 (1.1%)
Ethnicity
Hispanic or Latino 2 (0.8) 1 (0.5) 3 (0.7)
Not Hispanic or Latino 219 (91.6) 167 (89.8) 386 (90.8)
Not Answered 25 (10.2%) 26 (13.4%) 51 (11.6%)
Marital statusd
Married/live with a partner 171 (69.5) 151 (78.2) 322 (73.3)
Single or never married 6 (2.4) 9 (4.7) 15 (3.4)
Widowed/Divorced/Separated 69 (28.0) 32 (16.6) 101 (23.0)






Not Answered 12 (6.2%)
Educational attainmentd
Less than high school 20 (8.2) 9 (4.7) 29 (6.6)
High school graduate or GED 43 (17.6) 45 (23.3) 88 (20.1)
Some college 66 (27.0) 69 (35.8) 135 (30.9)
College graduate or more 114 (46.7) 70 (36.3) 184 (42.1)
Not Answered 3 (1.2%) 1 (0.5%) 4 (0.9%)
Household income
<20 K 39 (15.9) 27 (14.0) 66 (15.1)
20-39.9 K 49 (20.0) 32 (16.6) 81 (18.5)
40-59.9 K 48 (19.6) 46 (23.8) 94 (21.5)
60-79.9 K 49 (20.0) 34 (17.6) 83 (18.9)
Danis et al. BMC Health Services Research 2014, 14:315 Page 6 of 11
http://www.biomedcentral.com/1472-6963/14/315
Table 1 Socio-demographic characteristics and health status of patients (N = 246) and family members (N = 194)
(Continued)
80 + K 57 (23.3) 50 (25.9) 107 (24.4)
Not answered 4 (1.6%) 5 (2.6%) 9 (2.0%)
Health statusa,b
Poor 8 (3.3) 0 8 (1.8)
Fair 50 (20.3) 16 (8.3) 66 (15.0)
Good 93 (37.8) 75 (38.9) 168 (38.3)
Very good 70 (28.5) 73 (37.8) 143 (32.6)
Excellent 24 (9.8) 29 (15.0) 53 (12.1)
Not answered 1 (0.4) 1 (0.5%) 2 (0.5%)
Cancer type (self reported) Deceased N (%)
Breast 43 (17.5) 2 (4.6)
Lung 38 (15.4) 10 (26.3)
Prostate 37 (15.0) 4 (10.8)













Out-of pocket payments during the past 12 months
$0 11 (4.5) 6 (3.1) 17 (3.9)
<$500 20 (8.1) 37 (19.1) 57 (13.0)
$500 - < $2000 55 (22.4) 34 (17.5) 89 (20.2)
$2000 or more 124 (50.4) 95 (49.0) 219 (49.8)
Not Answered 36 (14.6) 22 (11.3) 58 (13.2)
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cancer treatment implying that these were not whimsical
choices. Rather, they understood the reality of cancer for
patients but were still willing to engage in tradeoffs. Second,
nearly half of all groups selected some level of unrestricted
cash, a benefit not provided by Medicare. Similarly, 32
groups selected home care (custodial long term care) atlevels beyond what Medicare currently covers and 33
selected one of two levels of concurrent palliative care.
Discussion
Worries about the sustainability of public benefit pro-
grams due to rising costs, and the countervailing pres-
sure to provide expansive benefits to seriously ill
Table 2 Overall frequency (%) of responses to the
post-CHAT questionnaire
Combined (N = 439%)a
Q1: Doing the CHAT exercise was:
1. Very enjoyable 318 (72.4)
2. Fairly enjoyable 100 (22.8)
3. Fairly un-enjoyable 5 (1.1)
4. Very un-enjoyable 9 (2.1)
N/A 7 (1.6)
Q2: Doing the CHAT exercise was:
1. Very easy to understand 259 (59.0)
2. Fairly easy to understand 172 (39.2)
3. Fairly hard to understand 1 (0.2)
4. Very hard to understand 0
N/A 7 (1.6)
Q3: Was doing the CHAT exercise:
1. Very informative 291 (66.3)
2. Fairly informative 135 (30.8)
3. Fairly uninformative 3 (0.7)
4. Very uninformative 2 (0.5)
N/A 8 (1.8)
aNo statistical significance was found between family members vs. patient
between these questions allowing us to pool the data.
Danis et al. BMC Health Services Research 2014, 14:315 Page 8 of 11
http://www.biomedcentral.com/1472-6963/14/315patients, is a seminal, and shared public policy conun-
drum across the industrialized world. The issue in the
case of cancer is particularly explosive due to the rap-
idly increasing therapy options and the understandable
inclination of patients to want more treatment options.
How do public benefit programs say no to expensive,
low value therapies?
We describe the modification and testing of a decision
tool for use by patients and families intended to address
this policy problem. The paper reports the consensus
benefit choices of elderly cancer patients covered by the
Medicare program in the U.S. (an entitlement program
that covers all elderly persons) and their family members,
arrived at after making individual judgments and smaller
group discussions. These consensus benefit choices are
made by persons who have actually been touched by
cancer-either as a patient or as a family member. Those
directly affected by this serious illness provide a key per-
spective to consider when determining what benefit options
are provided to beneficiaries suffering from the common
diagnosis of cancer. A notable finding is how infrequently
these groups (N = 4) chose the advanced level of cancer
treatment (that would require allocation of 42 of 50 stickers
to cancer treatment), even though this level of care is com-
monly provided in the U.S. Medicare program. Instead, the
consensus choices tended to provide for more balancedbenefits, including palliative care and long term care ser-
vices that address disability and the burdens of illness. For
example, 32 of 70 groups allocated some resources to unre-
stricted cash-a benefit not provided in the current Medicare
benefit package. Such selections came at a direct reduction
of currently covered benefits, and demonstrate that persons
who have experienced cancer were willing to engage in dif-
ficult tradeoffs that sometimes would result in allocating
scarce resources away from medical treatments only in
favor of a more balanced allocation. Similar shifts toward
non covered benefits were identified in concurrent pallia-
tive care and home based long term care.
A limitation of the study is that it is a hypothetical ex-
ercise-the choices made in the CHAT exercise did not
influence actual Medicare benefits, but the aim of the
CHAT exercise was to impose a resource constraint that
does not currently exist. The results of the study suggest
that individuals who have experienced or been touched
by significant illness such as cancer and thus might be
quite affected by insurance benefit decisions may be pre-
pared to explicitly confront the hard decisions inherent in
high cost-high stakes medicine that have been thought to
be so unapproachable if they are guided by carefully de-
signed decision aids like the CHAT exercise.
Given the plethora of therapies and uncertainty of
benefits in many cases of advanced disease, a key issue is
the need to reset the expectations of each patient, family
members, and providers regarding how to determine
what treatments are provided in public benefit programs
for cancer. The results reported here demonstrate that it
is possible to facilitate such conversations with those indi-
viduals who are likely to face the brunt of the consequences
of the insurance coverage decisions that will ensue. The
study does point out, however, differences between con-
clusions that people arrive at from group deliberations
in theoretical situations and the care that is provided by
the Medicare program as a matter of course to patients
with advanced disease such as cancer. For example, no
groups chose the most advanced level of cancer care of-
fered in this exercise, but the Medicare program rou-
tinely finances the ‘do everything’ version of cancer
therapy for beneficiaries. This contrast highlights a pro-
found separation between a Medicare enrollee’s under-
standing of the issues in the abstract when asked to
consider the policy issues related to resource constraints
and inclinations when actually receiving care under
coverage of the Medicare program. Of course, patients
do not receive the type of information and opportunity
to discuss these difficult decisions in a facilitated man-
ner in the normal functioning of the Medicare program.
A key issue for all industrialized nations is to determine
how to bring about meaningful discussion of the trade-
offs between types of benefits to inform the need to
make these programs fiscally sustainable.
Table 3 Overall frequency (%) of Likert responses to the post-CHAT questionnairea
Survey item 1 Strongly
disagree
2 3 Agree 4 5 Strongly
agree
N/A
Q4 When I think about CHAT I feel angry 312 (71.1) 34 (7.7) 43 (9.8) 16 (3.6) 29 (6.6) 5 (1.1)
Q5 When I think about CHAT I feel frustrated 276 (62.9) 61 (13.9) 49 (11.2) 17 (3.9) 25 (5.7) 11 (2.5)
Q6 The way the group reached its decision was fair 19 (4.3) 8 (1.8) 100 (22.8) 62 (14.1) 243 (55.4) 7 (1.6)
Q7 My views were considered and taken into account 15 (3.4) 4 (0.9) 91 (20.7) 68 (15.5) 255 (58.1) 6 (1.4)
Q8 During the CHAT I was treated with respect 16 (3.6) 2 (0.5) 55 (12.5) 47 (10.7) 310 (70.6) 9 (2.1)
Q9 What I wanted was considered by the group in arriving at a decision 16 (3.6) 8 (1.8) 84 (19.1) 77 (17.5) 249 (56.7) 5 (1.1)
Q10 Discussion during the CHAT was open and honest 17 (3.9) 2 (0.5) 72 (16.4) 46 (10.5) 300 (68.3) 2 (0.5)
Q11 Disagreements were resolved fairly 8 (1.8) 6 (1.4) 103 (23.5) 57 (13.0) 245 (55.8) 20 (4.6)
Q12 Information given to us was believable 11 (2.5) 9 (2.1) 105 (23.9) 75 (17.1) 223 (50.8) 16 (3.6)
Q13 We had enough information to make decisions 6 (1.4) 22 (5.0) 103 (23.5) 90 (20.5) 204 (46.5) 14 (3.2)
Q14 Choices given to us were realistic 10 (2.3) 17 (3.9) 107 (24.4) 89 (20.3) 195 (44.4) 21 (4.8)
Q15 My own choice of a plan is very different from what the group chose 135 (30.8) 138 (31.4) 60 (13.7) 52 (11.8) 32 (7.3) 22 (5.0)
Q16 All the choices I wanted were available to me 13 (3.0) 32 (7.3) 151 (34.4) 81 (18.5) 131 (29.8) 31 (7.1)
Q17 I was satisfied with the group’s decision 4 (0.9) 9 (2.1) 124 (28.2) 95 (21.6) 177 (40.3) 30 (6.8)
Q18 I would be willing to abide by the group’s choice of Medicare coverage 6 (1.4) 22 (5.0) 141 (32.1) 87 (19.8) 150 (34.2) 33 (7.5)
Q19 Asking cancer patients/families about what kind of Medicare benefits they
recommend is a good idea
6 (1.4) 6 (1.4) 77 (17.5) 69 (15.7) 250 (56.9) 31 (7.1)
Q20 Having cancer patients and families talk about their views in a group was a
good experience
8 (1.8) 6 (1.4) 81 (18.5) 64 (14.6) 252 (57.4) 28 (6.4)
Q21 I would rather not talk about the things we discussed today 270 (61.5) 74 (16.9) 26 (5.9) 14 (3.2) 25 (5.7) 30 (6.8)
Q22 I would like to have insurance for patients with cancer be spent on medical
care only
186 (42.4) 102 (23.2) 59 (13.4) 25 (5.7) 38 (8.7) 29 (6.6)
Q23 I would like to have insurance for cancer patients cover broader needs than
medical care alone
21 (4.8) 34 (7.7) 108 (24.6) 76 (17.3) 170 (38.7) 30 (6.8)
Q24 The presentation was effectively organized 4 (0.9) 4 (0.9) 75 (17.1) 65 (14.8) 259 (59.0) 32 (7.3)
Q25 The facilitator communicated effectively 6 (1.4) 1 (0.2) 64 (14.6) 63 (14.4) 275 (62.6) 30 (6.8)
aNot all participants answered every question.
Table 4 Frequency (%) of consensus groups (Consensus
round 3) choosing selected coverages (N = 70 groups)
Coverage 0 1 2 3 4
Treatment for cancer 27 (38.6) 39 (55.7) 4 (5.7)
Primary care 1 (1.4) 69 (98.6)
Palliative care 4 (5.7) 33 (47.1) 30 (42.9) 3 (4.3)
Other medical care 10 (14.3) 60 (85.7)
Nursing facility 5 (7.1) 27 (38.6) 38 (54.3)
House calls 51 (72.9) 19 (27.1)
Home improvement 21 (30.0) 34 (48.6) 12 (17.1) 3 (4.3)
Home care 5 (7.1) 33 (47.1) 22 (31.4) 10 (14.3)
Emotional 33 (47.1) 37 (52.9)
Drugs 11 (15.7) 59 (84.3)
Dental vision 13 (18.6) 57 (81.4)
Cosmetic care 19 (27.1) 51 (72.9)
Complementary 50 (71.4) 20 (28.6)
Cash 38 (54.3) 19 (27.1) 10 (14.3) 3 (4.3)
Advice 50 (71.4) 20 (28.6)
Coverage: 0 = no coverage, 4 = highest level of coverage.
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the expensive care of advanced cancer patients is not
merely a concern for the Medicare Program. The Ameri-
can Society for Clinical Oncology has recognized that the
costs of cancer care are burdensome for patients and their
families and has recommended that oncologists discuss
the costs of cancer treatments with their patients. Fojo
and Grady [11] as well as Smith and Hillner [12] have ar-
gued that the spiraling cost of cancer care, and particularly
cancer therapeutics that achieve only marginal benefits,
pose the need for guidance from oncologists about how to
address these costs. Yet there has been little opportunity
for cancer patients and their families to provide input into
priority setting for benefit coverage for cancer care of ad-
vanced cancer patients. Our results suggest that when a
structured process that allows for informed deliberation is
conducted, cancer patients and their families are able and
willing to explicitly discuss the burdensome costs of can-
cer care, the opportunity costs they pose, and their pre-
ferred benefit choices under the difficult circumstances
they face. Much work remains to be accomplished in
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http://www.biomedcentral.com/1472-6963/14/315identifying strategies to translate this understanding into
practice. To be effective, any new strategies will need to
handle patient and family expectations in ways that allow
for a financially sustainable coverage while at the same
time maintaining patients’ confidence that they are recei-
ving appropriate care.
This study has several limitations. First, like most focus
group studies that involve recruitment of individuals who
must be available for sessions that may not convenient for
all those eligible, this study includes participants who are
not a representative sample of elderly cancer patients.
Nonetheless, the study population does include indivi-
duals with varied ethnicity, income and education. Second,
as stated earlier, the exercise posed a hypothetical set of
choices. We cannot infer with certainty that participants
would engage in such a process as willingly or make the
same choices if they were posed in circumstances where
the consequences were more concrete.
Conclusion
Our results suggest that this CHAT exercise can be used
with cancer patients and their families to determine the na-
ture and scope of Medicare benefits that would be mean-
ingful to this clinical population. Exercises like this can be
helpful to inform policy questions about the alignment of
Medicare benefits specific to patients with advanced cancer.
Given the favorable responses from our sample, extension
of the CHAT exercise may prove to be useful with other
patient populations to help guide policy makers interested
in patient-centered health plan design.
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